Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries. The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired. The deal has already been approved by the boards of directors from both companies. Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery. Shockwave’s technology is used to treat coronary artery and peripheral artery disease. The company’s revenue jumped 49% last year to $730 million. |
First look: Alton Towers' 50mph Nemesis rollercoaster is unveiled to the public with a brandInside Croatia's abandoned haven of hedonism: The derelict remains of Haludovo Hotel, the onceInside Croatia's abandoned haven of hedonism: The derelict remains of Haludovo Hotel, the onceREVEALED: The eyeMother's shock after pub she'd visited for eight years cancelled her Sunday meal bookingA trip that'll be frozen in my memory forever: I survivedNet tightens on Bolsonaro as police seize passport in coup probeDon't be a tourist bored! Fascinating map reveals ONE THOUSAND amazing things to do, seeRevealed: The secret maleA brush with Van Gogh in picture